(Q42071725)

English

Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

positron emission tomography

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Michael J. Morris

7

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

4

object named as

Mithat Gönen

0 references

author name string

Gustavo S P Meirelles

1

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Heiko Schöder

2

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Gregory C Ravizzini

3

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Mithat Gönen

4

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Josef J Fox

5

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

John Humm

6

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Howard I Scher

8

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Steven M Larson

9

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

language of work or name

0 references

publication date

25 October 2010

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

16

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

24

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

6093-6099

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

5 June 2018

Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

5 June 2018

Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

5 June 2018

Positron emission tomography for prostate, bladder, and renal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

5 June 2018

Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

5 June 2018

Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

5 June 2018

Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

5 June 2018

On the comparison of correlated proportions for clustered data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

5 June 2018

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

5 June 2018

18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

17 August 2018

Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

17 August 2018

FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

17 August 2018

Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

17 August 2018

Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

17 August 2018

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

17 August 2018

[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

17 August 2018

Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

17 August 2018

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

17 August 2018

Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

17 August 2018

A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3402086

17 August 2018

Prognostic significance of bone metastases in patients with metastatic prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20975102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose

1 reference

https://pubmed.ncbi.nlm.nih.gov/20975102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of bony metastases of androgen-independent prostate cancer by PET-FDG

1 reference

https://pubmed.ncbi.nlm.nih.gov/20975102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20975102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-10-1357

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42071725&oldid=1933183940"